🇺🇸 FDA
Patent

US 10729651

Sustained release formulation of a non-steroidal anti-inflammatory drug

granted A61KA61K31/196A61K31/407

Quick answer

US patent 10729651 (Sustained release formulation of a non-steroidal anti-inflammatory drug) held by Pacira Pharmaceuticals, Inc. expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pacira Pharmaceuticals, Inc.
Grant date
Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/196, A61K31/407, A61K31/5415, A61K9/127